Digestives & Intestinal Remedies - France

France

Highlights

In France, the revenue generated in the Digestives & Intestinal Remedies market market amounts to US$356.40m in 2024.
It is projected that the market will experience an annual growth rate of 1.44% (CAGR 2024-2029).
When compared globally, China leads the market with a revenue of US$4.41bn in 2024.
In terms of per capita figures, each person in France generates US$5.49 in revenue in 2024.
France's increasing focus on natural and herbal remedies has led to a growing demand for digestive and intestinal remedies in the OTC Pharmaceuticals market.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in France has been experiencing steady growth in recent years.

Customer preferences: French consumers are increasingly turning to natural and herbal remedies for digestive and intestinal issues. This trend is driven by a growing interest in holistic health and a desire for more natural and sustainable products. Additionally, there is a preference for products that are easy to use and provide quick relief from symptoms.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in France is the rise of probiotics. Probiotic supplements and foods have gained popularity due to their ability to promote a healthy gut microbiome and improve digestion. Consumers are increasingly seeking out products that contain specific strains of probiotics and are backed by scientific research. Another trend in the market is the increasing demand for digestive enzymes. These enzymes help break down food and improve digestion, particularly for individuals with conditions such as lactose intolerance or irritable bowel syndrome. There is a growing awareness of the benefits of digestive enzymes, leading to an increase in their consumption.

Local special circumstances: France has a strong tradition of herbal medicine, which has influenced the Digestives & Intestinal Remedies market. Many French consumers prefer natural remedies that have been used for centuries and have a proven track record. This preference for traditional herbal remedies has contributed to the growth of the market for natural and herbal digestive and intestinal remedies.

Underlying macroeconomic factors: The Digestives & Intestinal Remedies market in France is also influenced by broader macroeconomic factors. The country has a well-developed healthcare system and a high level of healthcare expenditure. This provides a supportive environment for the growth of the market, as consumers have access to a wide range of products and are willing to spend on their health.In addition, France has an aging population, which is driving demand for digestive and intestinal remedies. As people age, they are more likely to experience digestive issues and seek out products to alleviate their symptoms. This demographic trend is expected to continue in the coming years, further fueling the growth of the market.Overall, the Digestives & Intestinal Remedies market in France is experiencing growth due to customer preferences for natural and herbal remedies, as well as the rise of probiotics and digestive enzymes. The country's strong tradition of herbal medicine and supportive healthcare system are also contributing factors. With an aging population and increasing awareness of digestive health, the market is expected to continue growing in the future.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.